Trial Site Detail

 

Drug:	Imatinib + Sunitinib + Regorafenib
Trial:	Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Oslo University Hospital       Oslo , 0424 Norway

 

Principal Investigator:	Mona-Elisabeth Revheim, MD
Contact:	+4723070840 mona.elisabeth.revheim@ous-hf.no
Activation Status of this Site:	Closed
Notes about this Site:
Oslo University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.